KRT19 and benign thyroid gland neoplasm: These include Hector Battifora mesothelial epitope-1 (HBME-1), cytokeratin 19 (CK19), and Galectin-3, which are the most widely recognized markers that are expressed in over 95% of PTC, with very low expression in benign thyroid neoplasms [39].